MedTrace Logo

Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.

NCT02690467 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-07-25

No results posted yet for this study

Summary

The purpose of this study is to determine the non-inferiority of a new Pic Insupen 34Gx3,5mm needle vs. a 32Gx4mm needle in terms of metabolic control, safety and acceptability in patients with diabetes treated with insulin.

Conditions

Interventions

DEVICE

Insupen G34x3,5mm

DEVICE

Insupen G32x4mm

Sponsors & Collaborators

  • Artsana S.p.a.

    collaborator INDUSTRY

  • Center for Outcomes Research and Clinical Epidemiology, Italy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2017-03-23
Completion
2017-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02690467 on ClinicalTrials.gov